Possible Bearish Signals With Henry Schein Insiders Disposing Stock
Many Henry Schein, Inc. (NASDAQ:HSIC) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating insider transactions, knowing whether i
Henry Schein to Present at Investor Conferences in June 2024
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor
Why Henry Schein (HSIC) Is a Top Momentum Stock for the Long-Term
Henry Schein Mobilizes Support for Recovery Efforts in Brazil
Company Commits Over $200,000 in Cash and Health Care Product Donations, Matches Employee Contributions In the wake of the devastation caused by the flooding in Brazil, Henry Schein, Inc. (NASDAQ:HSIC) is raising
Henry Schein Extends Special Olympics Sponsorship Through 2025
Henry Schein (HSIC) said Monday it has extended its partnership with Special Olympics through 2025. The company said it will provide oral health and medical care products to athletes at Special Olympi
Looking Into Henry Schein's Recent Short Interest
Henry Schein's (NYSE:HSIC) short percent of float has fallen 4.69% since its last report. The company recently reported that it has 5.24 million shares sold short, which is 4.67% of all regular shares
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Price Target Raised to $92.00/Share From $90.00 by Barrington Research
Henry Schein Price Target Raised to $92.00/Share From $90.00 by Barrington Research
Express News | Barrington Research Maintains Outperform on Henry Schein, Raises Price Target to $92
Lucas Systems Announces 100 Billion Warehouse Picks
Credits Continuous Innovation of Technologies Centered Around WorkersWEXFORD, Pa., May 8, 2024 /PRNewswire/ -- Warehouse workers made 100 billion warehouse picks using Lucas Systems software, accordi
UBS Adjusts Price Target on Henry Schein to $80 From $82, Maintains Neutral Rating
Henry Schein (HSIC) has an average hold rating and price target range of $65 to $90, according to analysts polled by Capital IQ. Price: 73.67, Change: +2.47, Percent Change: +3.46
Express News | Henry Schein Inc : UBS Cuts Target Price to $80 From $82
Expert Outlook: Henry Schein Through The Eyes Of 7 Analysts
In the last three months, 7 analysts have published ratings on Henry Schein (NASDAQ:HSIC), offering a diverse range of perspectives from bullish to bearish.The following table summarizes their recent
Henry Schein Price Target Cut to $80.00/Share From $82.00 by UBS
Henry Schein Price Target Cut to $80.00/Share From $82.00 by UBS
Henry Schein Is Maintained at Neutral by UBS
Henry Schein Is Maintained at Neutral by UBS
Express News | UBS Maintains Neutral on Henry Schein, Lowers Price Target to $80
Henry Schein Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 12.44% UBS $82 → $80 Maintains Neutral 03/06/2024 23.68% JP Morgan $82 → $88 Maintains Overweig
Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC) and Esperion (ESPR)
Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating
Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating.
Express News | Henry Schein Inc : Barrington Research Raises Target Price to $92 From $90